跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAXCARD MODIFIED RELEASE TABLETS 35MG - HSA Drug Approval Details
Approvals
/
HSA
/
MAXCARD MODIFIED RELEASE TABLETS 35MG
Approved
THERAPEUTIC
MAXCARD MODIFIED RELEASE TABLETS 35MG
USV Private Limited
🇸🇬 Health Sciences Authority
Approval Date
Sep 28, 2016
Approval ID
e2f1572627aec3b8
Company
USV Private Limited
Type
Therapeutic
Approval Details
Approval Id
e2f1572627aec3b8
Drug Name
MAXCARD MODIFIED RELEASE TABLETS 35MG
Product Name
MAXCARD MODIFIED RELEASE TABLETS 35MG
Approval Number
SIN15092P
Approval Date
2016-09-28
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route Of Administration
ORAL
Atc Code
C01EB15
Atc Item Name
trimetazidine
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Trimetazidine Dihydrochloride
35mg
TRIMETAZIDINE DIHYDROCHLORIDE
35 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 28, 2016
Approval ID
e2f1572627aec3b8
Type
Therapeutic
Back to HSA Approvals